Future studies are needed to compare the levels of these proteins between patients with type I vs. type II diabetes to differentiate whether type I and type II diabetes have different effects on the expression of ASC, IL-18, CRP, uPA, EGF, and NGAL. This evidence concerns the gene PLAU and type 2 diabetes mellitus.